Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects.
Int J Cancer. 2006 May 15;118(10):2412-20. doi: 10.1002/ijc.21682.
Int J Cancer. 2006.
PMID: 16353157
Free article.
Role of protein kinase Czeta in thrombin-induced endothelial permeability changes: inhibition by angiopoietin-1.
Li X, Hahn CN, Parsons M, Drew J, Vadas MA, Gamble JR.
Li X, et al.
Blood. 2004 Sep 15;104(6):1716-24. doi: 10.1182/blood-2003-11-3744. Epub 2004 Jun 1.
Blood. 2004.
PMID: 15172966
Free article.
Item in Clipboard
Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions.
Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, Vadas MA.
Gamble JR, et al.
Circ Res. 2000 Sep 29;87(7):603-7. doi: 10.1161/01.res.87.7.603.
Circ Res. 2000.
PMID: 11009566
Item in Clipboard
Tea tree oil reduces the swelling associated with the efferent phase of a contact hypersensitivity response.
Brand C, Grimbaldeston MA, Gamble JR, Drew J, Finlay-Jones JJ, Hart PH.
Brand C, et al. Among authors: drew j.
Inflamm Res. 2002 May;51(5):236-44. doi: 10.1007/pl00000299.
Inflamm Res. 2002.
PMID: 12056511
Item in Clipboard
Prospective histomorphometric and DXA evaluation of bone remodeling in imatinib-treated CML patients: evidence for site-specific skeletal effects.
Vandyke K, Fitter S, Drew J, Fukumoto S, Schultz CG, Sims NA, Yeung DT, Hughes TP, Zannettino AC.
Vandyke K, et al.
J Clin Endocrinol Metab. 2013 Jan;98(1):67-76. doi: 10.1210/jc.2012-2426. Epub 2012 Nov 8.
J Clin Endocrinol Metab. 2013.
PMID: 23144472
Clinical Trial.
Item in Clipboard
NVP-BEZ235, a dual pan class I PI3 kinase and mTOR inhibitor, promotes osteogenic differentiation in human mesenchymal stromal cells.
Martin SK, Fitter S, Bong LF, Drew JJ, Gronthos S, Shepherd PR, Zannettino AC.
Martin SK, et al. Among authors: drew jj.
J Bone Miner Res. 2010 Oct;25(10):2126-37. doi: 10.1002/jbmr.114.
J Bone Miner Res. 2010.
PMID: 20499346
Free article.
Item in Clipboard
Cite
Cite